Publikationen

Zeige 1 bis 10 von 11 Ergebnissen

Footer

Betrieben von

Universität Münster
Abteilung 6.4: Forschungsinformationen & Forschungsberichterstattung
Domplatz 6-7 | 48143 Münster
cris@uni-muenster.de

Top-Links

Über die Universität Münster
Forschungsprofil der Universität Münster
CRIS-Login

wissen.leben

Impressum | Datenschutz | Barrierefreiheit

Suche

Schrader, Andres Jan

Zeige 1 bis 10 von 11 Ergebnissen

Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017) In: ((Bitte Journal prüfen)), 71. Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017) In: ((Bitte Journal prüfen)), 18. Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Influence of statins on survival outcome in patients with metastatic castration resistant prostate cancer treated with abiraterone acetate Boegemann M., Schlack K., Fischer A., Gerß J., Steinestel J., Semjonow A., Schrader A., Krabbe L. (2016) In: PloS one, 11(9). doi:10.1371/journal.pone.0161959 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
The safety and efficacy of gemcitabine for the treatment of bladder cancer Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 16(3). Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells Steinestel K., Eder S., Ehinger K., Schneider J., Genze F., Winkler E., Wardelmann E., Schrader A., Steinestel J. (2016) In: Tumor Biology, 37(5), 6275-6283. doi:10.1007/s13277-015-4509-5 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Erratum to: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells (Tumor Biol., DOI 10.1007/s13277-015-4509-5) In: , . \| Peer reviewed
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer In: . \| Peer reviewed
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate In: . \| Peer reviewed
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer In: . \| Peer reviewed
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? In: . \| Peer reviewed

Steinestel K., Eder S., Ehinger K., Schneider J., Genze F., Winkler E., Wardelmann E., Schrader A., Steinestel J.

(2016)

Tumor Biology

, 37

(2)

2773

doi:10.1007/s13277-015-4659-5